These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21953053)

  • 1. From cell regulation to patient survival: 2nd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, Budapest, 2-5 May 2011.
    Umansky V; Malyguine A; Kotlan B; Aptsiauri N; Shurin MR
    Cancer Immunol Immunother; 2012 Feb; 61(2):295-301. PubMed ID: 21953053
    [No Abstract]   [Full Text] [Related]  

  • 2. Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): moving forward.
    Malyguine A; Umansky V; Kotlan B; Aptsiauri N; Shurin MR
    J Immunotoxicol; 2012; 9(3):231-5. PubMed ID: 22639903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conference Scene: Immunotherapy reaches new milestones in cancer eradication.
    Kotlan B; Umansky V; Malyguine AM; Marincola FM; Shurin MR
    Immunotherapy; 2011 Oct; 3(10):1131-7. PubMed ID: 21995567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapy and immunomonitoring (CITIM): redefining cancer therapy.
    Malyguine A; Umansky V; Shurin MR
    J Immunotoxicol; 2009 Dec; 6(4):205-8. PubMed ID: 19908938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22-25 April 2013, Krakow, Poland.
    Shurin MR; Umansky V; Malyguine A; Hurwitz AA; Apte RN; Whiteside T; Jewett A; Thanavala Y; Murphy WJ
    Cancer Immunol Immunother; 2014 Jan; 63(1):73-80. PubMed ID: 24271210
    [No Abstract]   [Full Text] [Related]  

  • 6. Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia.
    Aptsiauri N; Jewett A; Hurwitz AA; Shurin MR; Umansky V
    Cancer Immunol Immunother; 2016 Jul; 65(7):875-83. PubMed ID: 26810566
    [No Abstract]   [Full Text] [Related]  

  • 7. New perspectives in cancer immunotherapy and immunomonitoring.
    Umansky V; Malyguine A; Shurin M
    Future Oncol; 2009 Sep; 5(7):941-4. PubMed ID: 19792962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interdisciplinary meeting on experimental and translational research in head and neck cancer : 12th Symposium of the Working Group Oncology, 2nd International Symposium on Immunosuppression and Immunotherapy in Cancer].
    Hoffmann TK; Brunner C; Schuler PJ
    HNO; 2023 Apr; 71(4):274-275. PubMed ID: 36879121
    [No Abstract]   [Full Text] [Related]  

  • 9. Conference scene: Immune signatures in the tumor and beyond.
    Kandalaft LE; Kalos M; Melief CJ; Speiser DE; Coukos G
    Immunotherapy; 2012 Aug; 4(8):761-72. PubMed ID: 22947003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapies.
    Kosoff D; Krueger T; Lang JM
    Immunotherapy; 2013 Nov; 5(11):1243-54. PubMed ID: 24188678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy.
    Legut M; Cole DK; Sewell AK
    Cell Mol Immunol; 2015 Nov; 12(6):656-68. PubMed ID: 25864915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, Germany.
    Diken M; Widenmeyer M; Gouttefangeas C; Welters MJ; Britten CM
    Cancer Immunol Immunother; 2010 Sep; 59(9):1417-23. PubMed ID: 19771427
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies.
    Bot A; Ahn M; Bosch M; Brockstedt D; Butterfield LH; Cornforth A; Harrop R; Kast WM; Koya R; Marincola F; Margolin K; McCoy C; Pawelec G; Rothman J; Ramirez-Montagut T; Schlom J; Srivastava P; Wallis S; Walter S; Wang E; Waslif J
    J Transl Med; 2012 Nov; 10():218. PubMed ID: 23127127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. 30 October-2 November 2003, Bethesda, Maryland, USA.
    Marincola FM; Wang E; Atkins MB
    Expert Opin Biol Ther; 2004 Jan; 4(1):107-14. PubMed ID: 14680473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CTCFL/BORIS for the immunotherapy of cancer.
    Loukinov D
    Cancer Immunol Immunother; 2018 Dec; 67(12):1955-1965. PubMed ID: 30390146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated antigens: considerations for their use in tumour immunotherapy.
    Linley AJ; Ahmad M; Rees RC
    Int J Hematol; 2011 Mar; 93(3):263-273. PubMed ID: 21360066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer labs reach beyond exhausted T cells.
    Marx V
    Nat Methods; 2020 Apr; 17(4):367-370. PubMed ID: 32203391
    [No Abstract]   [Full Text] [Related]  

  • 18. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
    Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
    Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
    [No Abstract]   [Full Text] [Related]  

  • 19. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
    Diken M; Attig S; Grunwitz C; Kranz L; Simon P; van de Roemer N; Vascotto F; Kreiter S
    Hum Vaccin Immunother; 2013 Sep; 9(9):2025-32. PubMed ID: 23877042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSPG4: a prototype oncoantigen for translational immunotherapy studies.
    Rolih V; Barutello G; Iussich S; De Maria R; Quaglino E; Buracco P; Cavallo F; Riccardo F
    J Transl Med; 2017 Jul; 15(1):151. PubMed ID: 28668095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.